SEC Form 4 · accession 0001055726-16-000056
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Simon X Benito
Director
Period of report
May 18, 2016
Accepted (ET)
May 18, 2016 · 4:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 18, 2016 | M | 6,250 | $8.92 | A | 24,048 | D | |
| Common Stock | May 18, 2016 | S | 6,250 | $10.371 | D | 17,798 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Options | $8.92 | May 18, 2016 | M | 6,250 | D | Jun 6, 2006 | Jun 6, 2016 | Common Stock | 6,250 | 0 | D |